tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

APTO Stock Latest News

Aptose Biosciences Advances TUSCANY Trial Dosage Escalation
Company AnnouncementsAptose Biosciences Advances TUSCANY Trial Dosage Escalation
1d ago
8K
APTO
Aptose Biosciences approved to escalate dose in Phase 1/2 AML trial
PremiumThe Fly
Aptose Biosciences approved to escalate dose in Phase 1/2 AML trial
1d ago
APTO
Aptose Biosciences Announces Reverse Share Split
PremiumCompany Announcements
Aptose Biosciences Announces Reverse Share Split
3d ago
8K
APTO
Aptose Biosciences announces 1-for-30 reverse share split
PremiumThe Fly
Aptose Biosciences announces 1-for-30 reverse share split
3d ago
APTO
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
7d ago
XLO
ABBV
Aptose Biosciences Secures $25M Share Purchase Agreement
PremiumCompany AnnouncementsAptose Biosciences Secures $25M Share Purchase Agreement
8d ago
8K
APTO
Aptose Biosciences files to sell 12.03M shares of common stock for holders
Premium
The Fly
Aptose Biosciences files to sell 12.03M shares of common stock for holders
8d ago
APTO
Aptose Biosciences Establishes $25M Equity Facility
Premium
Company Announcements
Aptose Biosciences Establishes $25M Equity Facility
8d ago
8K
APTO
Promising Results from Aptose Biosciences’ TUSCANY Trial Boost Joseph Pantginis’ Buy Rating
PremiumRatings
Promising Results from Aptose Biosciences’ TUSCANY Trial Boost Joseph Pantginis’ Buy Rating
9d ago
APTO
Promising Early Results from Aptose’s TUSCANY Trial in AML Treatment
PremiumCompany Announcements
Promising Early Results from Aptose’s TUSCANY Trial in AML Treatment
9d ago
APTO
Aptose reports ‘promising’ early safety data from Phase 1/2 TUSCANY trial
PremiumThe Fly
Aptose reports ‘promising’ early safety data from Phase 1/2 TUSCANY trial
9d ago
APTO
Aptose Biosciences Initiates TUSCANY Trial for Frontline AML Therapy
PremiumCompany Announcements
Aptose Biosciences Initiates TUSCANY Trial for Frontline AML Therapy
1M ago
APTO
Aptose announces first AML patients dosed in TUSCANY trial
PremiumThe FlyAptose announces first AML patients dosed in TUSCANY trial
1M ago
APTO
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
NVO
APTO
Aptose Biosciences Granted Nasdaq Compliance Extension
Premium
Company Announcements
Aptose Biosciences Granted Nasdaq Compliance Extension
2M ago
8K
APTO
Aptose Biosciences granted extension to regain compliance with Nasdaq
PremiumThe Fly
Aptose Biosciences granted extension to regain compliance with Nasdaq
2M ago
APTO
Aptose Biosciences Publishes Promising Preclinical Data on Tuspetinib
PremiumCompany Announcements
Aptose Biosciences Publishes Promising Preclinical Data on Tuspetinib
2M ago
8K
APTO
Aptose Biosciences announces publication of preclinical data on tuspetinib
PremiumThe Fly
Aptose Biosciences announces publication of preclinical data on tuspetinib
2M ago
APTO
Aptose Biosciences Advances TUS as AML Therapy
PremiumCompany Announcements
Aptose Biosciences Advances TUS as AML Therapy
2M ago
8K
APTO
Aptose Biosciences announces clinical data on tuspetinib
PremiumThe FlyAptose Biosciences announces clinical data on tuspetinib
2M ago
APTO
Aptose and NCI Collaborate on Cancer Drug Trials
Premium
Company Announcements
Aptose and NCI Collaborate on Cancer Drug Trials
3M ago
APTO
Aptose Biosciences signs CRADA with NCI to develop tuspetinib for AML, MDS
Premium
The Fly
Aptose Biosciences signs CRADA with NCI to develop tuspetinib for AML, MDS
3M ago
APTO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >